Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Dolalgial
Synonyms :
clonixin, Clonixino
Class :
Analgesic, Anti-inflammatory, Antipyretic, NSAID, Platelet-inhibition agent
Dosage Forms & StrengthsÂ
TabletÂ
125 mgÂ
250 mgÂ
300 mgÂ
Injectable SolutionÂ
200 mgÂ
Its main use is in the treatment of certain soft tissue illnesses that cause pain and inflammation as well as persistent arthritic diseases
One to two tablets are typically administered to adults, with the possibility of varying dosages (125 mg, 250 mg, or 300 mg) after an 8-hour break
Case-by-case adjustments and customizations are made to the recommended dosage
Treatment might last anywhere from seven to ten days—or even longer—depending on the unique medical needs of each patient
200 mg IV is advised for the treatment of pain after traumatology and ambulatory vascular surgery
Dose Adjustments
Limited data is available
Safety and efficacy are not seen in pediatricsÂ
Refer to the adult dosingÂ
the administration of clonixin may reduce the rate at which abacavir is excreted, potentially leading to an increase in serum levels
clonixin may lessen acebutolol's protective effects against hypertension
using clonixin in conjunction with abciximab may increase the likelihood or extent of bleeding and hemorrhaging
aceclofenac and clonixin together may increase the likelihood or extent of side effects
acemetacin and clonixin used together may increase the likelihood or extent of side effects
giving clonixin a shot may slow down the drug's excretion rate, which could lead to higher serum concentrations
almotriptan and clonixin together may increase the chance or extent of hypertension
clonixin may slow down the drug's elimination rate, which could result in elevated serum levels
clonixin may slow down the drug's elimination rate, which could lead to higher serum concentrations
combining alteplase with clonixin may enhance the chance or extent of bleeding and hemorrhage
Actions and Spectrum:Â
Actions:Â
Clonixin is categorized as an analgesic, non-steroidal anti-inflammatory medication (NSAID). It has been shown to suppress prostaglandin synthesis and block inward calcium currents.Â
Spectrum:Â
Clonixin therapy is indicated for the relief of headaches, joint pain, muscle aches, earaches, toothaches, and menstrual pain, as well as post-surgery, post-trauma, and gynecological discomfort.Â
Frequency not definedÂ
DizzinessÂ
NauseaÂ
SomnolenceÂ
ConstipationÂ
Dry mouthÂ
Gastric perforationÂ
GI bleedingÂ
Peptic ulcerÂ
ManiaÂ
VomitingÂ
SweatingÂ
Black Box Warning:Â
Clonixin primarily provides symptomatic relief, particularly in pain management, without addressing the underlying cause of the pain. Before integrating Clonixin into the treatment of chronic conditions, it is crucial to conduct clinical tests assessing blood count, kidney and liver function, and urine analysis. Regular monitoring of essential parameters is essential for timely detection of adverse effects and facilitating the prompt discontinuation of the drug.
When using clonixin as monotherapy for inflammation and pain associated with an infection, there is a chance of the infection spreading to other tissues; hence, concurrent use of appropriate antibiotics is necessary. Caution is advised when combining Clonixin with other anti-inflammatory drugs unless absolutely necessary. Similar to other systemic NSAIDs (excluding aspirin), clonixin use may increase the risk of cardiovascular thrombotic events, including myocardial infarction and stroke, potentially leading to fatality.
This risk escalates with higher doses and prolonged usage. Therefore, before prescribing Clonixin for extended periods, patients should undergo evaluation for the risk of cardiovascular events and receive regular monitoring during treatment. To minimize this risk, the lowest effective daily dose of clonixin should be employed for the shortest possible duration.Â
Contraindication/Caution:Â
ContraindicationsÂ
CautionsÂ
Pregnancy consideration:Â Â
No data is available regarding the administration of the drug during pregnancy.Â
Breastfeeding warnings:Â Â
No data is available regarding the excretion of drug in breast milk.Â
Pregnancy category:Â
Category A: well-controlled and satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: No data is available for the drug under this category.Â
Pharmacology:Â
Classified as a non-steroidal agent, clonixin is a compound of aniline and nicotinic acid with structural similarities to flufenamic acid. Along with its modest gastrointestinal side effects, it has analgesic and antipyretic benefits. Clonixin’s mechanism of action is still poorly understood at the molecular level. However, it is thought to work similarly to other NSAIDs. This entails the suppression of both cyclooxygenase 1 and 2, which lowers the synthesis of prostaglandins.Â
Pharmacodynamics:Â
Clonixin is a member of the non-steroidal anti-inflammatory medication (NSAID) class and shares a structure similar to that of Diclofenac. It induces vasodilation and produces analgesic effects.Â
Pharmacokinetics:Â
AbsorptionÂ
The bioavailability is 75%Â
The time to achieve peak effect is 15 minutes.Â
DistributionÂ
The volume of distribution is 1.14 to 1.29 L in children where it is not effective.Â
MetabolismÂ
Clonixin undergoes substantial hepatic metabolism, leading to the generation of hydroxylated and hydroxymethylated metabolites. Â
Elimination and ExcretionÂ
The half-life is 1.5 – 1.7 hours.Â
Â
Administration:Â
The application of clonixin entails adhering to prescribed protocols for its delivery. Commonly, it is orally administered in the form of tablets, capsules, or oral solutions. In certain situations, intravenous injection may be employed, especially within a healthcare environment.
The precise dosage, frequency, and method of administration vary based on the specific medical condition, individual patient factors, and recommendations from healthcare providers.
It is essential for patients to diligently adhere to the prescribed administration instructions and communicate any existing medical conditions, allergies, or concurrent medications to healthcare professionals, ensuring the secure and effective utilization of clonixin.Â
Patient information leafletÂ
Generic Name: clonixinÂ
Pronounced: kloh-niks-inÂ
Why do we use clonixin?Â
As a non-steroidal anti-inflammatory medicine (NSAID) with analgesic qualities, clonixin is used to reduce inflammation and relieve pain in a number of different medical disorders. The main goals of using clonixin include:Â Â
Pain Relief: Clonixin effectively relieves mild to moderate pain that is brought on by ailments like headaches, toothaches, muscle soreness, and menstrual cramps. Â
Reduced Inflammation: Clonixin, an NSAID, reduces inflammation by preventing the body from producing prostaglandins, which are chemicals that cause pain and inflammation. Fever Reduction: Those suffering from fever-related ailments can also use clonixin to reduce their fever.Â